DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Referenz

Ychou M, Raoul J, Douillard J et al. , for the GI Group of the FNCLCC and the FFCD
A phase III randomized trial of LV5FU2+CPT-11 vs. LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord02 / FFCD9802).

Journal of Clinical Oncology 2005; ASCO Annual Meeting Proceedings 2005
23: Abstract 3502 (Suppl 16, Part I of II):

Bibliographische Angaben herunterladen

Suchen in: